Emma De Winton - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Journal of Investigative Medicine High Impact Case Reports|May 16, 2020

Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic TherapyLouise Wade, Paul Kitching, Emma De Winton

Case Reports in Oncology|April 24, 2018

Non-Gestational Choriocarcinoma with Widespread Metastases Presenting with Type 1 Respiratory Failure in a 39-Year-Old Female: Case Report and Review of the LiteratureLouisa Stockton, Elizabeth Green, Baljeet Kaur, et al.

Journal of Medical Imaging and Radiation Oncology|August 14, 2012

Target localisation for tumour bed radiotherapy in early breast cancerCarmen J Hansen, Emma de Winton, Sam Guglani, et al.

BMJ Open|January 11, 2015

Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastasesAmelia O Clive, Paula Wilson, Hazel Taylor, et al.

The Lancet. Oncology|July 9, 2023

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trialChristopher Nutting, Laura Finneran, Justin Roe, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021

Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active MonitoringJenny F Seligmann, David J Fisher, Louise C Brown, et al.

Clinical and Translational Radiation Oncology|July 6, 2021

A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemicIfigenia Vasiliadou, David Noble, Andrew Hartley, et al.

Lancet (London, England)|November 20, 2018

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialHisham Mehanna, Max Robinson, Andrew Hartley, et al.

European Journal of Cancer (Oxford, England : 1990)|October 5, 2018

Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.

The Lancet. Oncology|June 28, 2016

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trialAmelia O Clive, Hazel Taylor, Lee Dobson, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Journal of Investigative Medicine High Impact Case Reports|May 16, 2020

Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic TherapyLouise Wade, Paul Kitching, Emma De Winton

Case Reports in Oncology|April 24, 2018

Non-Gestational Choriocarcinoma with Widespread Metastases Presenting with Type 1 Respiratory Failure in a 39-Year-Old Female: Case Report and Review of the LiteratureLouisa Stockton, Elizabeth Green, Baljeet Kaur, et al.

Journal of Medical Imaging and Radiation Oncology|August 14, 2012

Target localisation for tumour bed radiotherapy in early breast cancerCarmen J Hansen, Emma de Winton, Sam Guglani, et al.

BMJ Open|January 11, 2015

Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastasesAmelia O Clive, Paula Wilson, Hazel Taylor, et al.

The Lancet. Oncology|July 9, 2023

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trialChristopher Nutting, Laura Finneran, Justin Roe, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021

Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active MonitoringJenny F Seligmann, David J Fisher, Louise C Brown, et al.

Clinical and Translational Radiation Oncology|July 6, 2021

A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemicIfigenia Vasiliadou, David Noble, Andrew Hartley, et al.

Lancet (London, England)|November 20, 2018

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialHisham Mehanna, Max Robinson, Andrew Hartley, et al.

European Journal of Cancer (Oxford, England : 1990)|October 5, 2018

Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.

The Lancet. Oncology|June 28, 2016

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trialAmelia O Clive, Hazel Taylor, Lee Dobson, et al.

Pageof 2